_x000D_
_x000D_
_x000D_
_x000D_
Verdant Partners LLC_x000D_
_x000D_
Thomas F. Hughes Partner_x000D_
_x000D_
_x000D_
Verdant Partners LLC_x000D_
_x000D_
Thomas F. Hughes Partner_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Thomas Hughes, partner at Verdant Partners, discusses the increased acceptance of biotech around the world and what the future of biotech looks like._x000D_
_x000D_
_x000D_
Thomas Hughes, partner at Verdant Partners, discusses the increased acceptance of biotech around the world and what the future of biotech looks like._x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Thomas Hughes, partner at Verdant Partners, talks about the next wave of traits such as drought tolerance and nitrogen utilization as well as the timeline for this next generation of traits._x000D_
_x000D_
_x000D_
Thomas Hughes, partner at Verdant Partners, talks about the next wave of traits such as drought tolerance and nitrogen utilization as well as the timeline for this next generation of traits._x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
_x000D_
Some have hinted that the regulatory system in the United States is holding up the commercialization of some of these new traits. Thomas Hughes of Verdant Partners shares his opinion in regards to the regulatory process in the United States including what the seed industry can do to help the process._x000D_
_x000D_
_x000D_
Some have hinted that the regulatory system in the United States is holding up the commercialization of some of these new traits. Thomas Hughes of Verdant Partners shares his opinion in regards to the regulatory process in the United States including what the seed industry can do to help the process._x000D_
_x000D_
_x000D_
_x000D_